--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Kay Amblyopia Tracker" developer_entity: "Kay Pictures Ltd" bundle_id: "uk.co.kaypictures.AmblyopiaTest" app_store_id: "1505210585" google_play_id: "uk.co.kaypictures.amblyopiatest" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2024-07-10" report_date: "2026-09-17" last_verified: "2026-09-17T00:00:00.000Z" report_version: "3.0" total_reviews: 0 confidence: "low" confidence_score: 0.3 data_age_days: 13 momentum_velocity: "zombie" intelligence_version: 2 tags: ["medical", "free", "mobile app", "app review", "app analysis", "professionals", "managing", "pediatric"] canonical_url: "https://marlvel.ai/apps/kay-amblyopia-tracker" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Kay Amblyopia Tracker Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** Kay Amblyopia Tracker is a medical app by Kay Pictures Ltd, available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Kay Amblyopia Tracker is a medical app by Kay Pictures Ltd. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | Kay Pictures Ltd | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 13d | ## Metadata & Market Performance - **Publisher:** Kay Pictures Ltd - **Category:** Medical - **Target Audience:** Eye professionals managing pediatric amblyopia and the parents of patients under their care. - **Platforms:** iOS & Android - **Version Reviewed:** 3.0 - **Report Date:** 2026-09-17 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1505210585 - **Bundle ID:** uk.co.kaypictures.AmblyopiaTest - **Google Play ID:** uk.co.kaypictures.amblyopiatest - **Data Window:** Analysis based on signals collected up to 2026-09-17 ## Executive Snapshot **What it is:** Kay Amblyopia Tracker is a professional-grade vision monitoring tool for pediatric amblyopia patients, accessible via clinician-provided activation codes on iOS and Android. **Why users hire it:** The app removes the logistical friction of frequent clinic visits by enabling home-based tracking of vision changes that parents can share with eye professionals. ## App DNA (Features & Intent) - **[Differentiator] Home Vision Monitoring:** Automated vision testing using validated optotypes for children from 24 months of age. - **[Differentiator] Activation Code System:** Restricts access to patients authorized by eye professionals, maintaining clinical control. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Progress Charting:** Visualizes test results to encourage treatment compliance and inform follow-up frequency. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Kay Amblyopia Tracker maintains a specialized position as a clinical utility, with no public rating count across iOS or Android. Its value proposition rests on professional-led distribution, insulating it from the discovery-based competition typical of the medical category. ## Monetization Strategy - **Model:** Free - **Tiers:** Free to download and use with professional-provided activation code - **Analysis:** The app functions as a B2B tool within the broader Kay Pictures clinical ecosystem, where monetization is tied to professional clinical products rather than end-user fees. ## SWOT Analysis {#swot} **Core Strengths:** - Validated optotypes ensure clinical authority - Activation code system enforces B2B care pathways - Home-testing workflow reduces clinic dependency **Growth Levers:** - International expansion via 21-language library - Integration with electronic health record systems ## What's New - **Latest (v3.0, 2 years ago):** Optimized the internal testing workflow for improved efficiency. ## App Momentum (Zombie) {#momentum} - Dormant development, last release July 2024. - Zero public store ratings recorded. > **Cadence:** 1 total versions · 1 majors in last 6 months · 803 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Kay Amblyopia Tracker is a medical app that is completely free. > **Bottom Line:** Kay Amblyopia Tracker functions as a B2B clinical utility that relies on professional endorsement to maintain its position. Addressing the two-year development dormancy is necessary to ensure the app remains a reliable tool for ongoing patient management. **Best for:** Eye professionals managing pediatric amblyopia and the parents of patients under their care. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit clinical partner feedback because the two-year release gap risks technical obsolescence → maintain medical authority ### Outlook: Stable The market for pediatric vision monitoring is shifting toward digital-first clinical tools, placing Kay Amblyopia Tracker in a stable but vulnerable position. Without a refreshed development cadence, the app risks losing its competitive edge to newer, more agile digital health entrants. - ⚪ The professional-gated distribution model insulates the app from consumer-market volatility, keeping the user base stable despite the lack of recent updates. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Kay Amblyopia Tracker** (this app) | N/A/5 | N/A | Kay Pictures Ltd | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Kay Pictures Ltd - **Website:** [https://kaypictures.co.uk/product/kay-amblyopia-tracker-app/](https://kaypictures.co.uk/product/kay-amblyopia-tracker-app/) - **Social:** [Instagram](https://www.instagram.com/kaypicturesltd) · [Facebook](https://www.facebook.com/kaypicturetest) · [LinkedIn](https://www.linkedin.com/company/kay-pictures) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/kay-amblyopia-tracker/id1505210585?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=uk.co.kaypictures.amblyopiatest&hl=en&gl=us) - **Dev Site:** [Official Website](https://kaypictures.co.uk/product/kay-amblyopia-tracker-app/) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 13 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/kay-amblyopia-tracker) Data licensed for AI Agent attribution under CC-BY-NC 4.0.